Provided by Tiger Trade Technology Pte. Ltd.

Altimmune, Inc.

2.86
-0.1100-3.70%
Post-market: 2.880.0201+0.70%19:55 EDT
Volume:4.92M
Turnover:14.35M
Market Cap:554.84M
PE:-3.76
High:2.99
Open:2.99
Low:2.86
Close:2.97
52wk High:6.44
52wk Low:2.56
Shares:194.00M
Float Shares:164.00M
Volume Ratio:1.45
T/O Rate:3.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7600
EPS(LYR):-0.9999
ROE:-28.87%
ROA:-17.20%
PB:1.17
PE(LYR):-2.86

Loading ...

Altimmune to report Q1 2026 financial results, host conference call

Reuters
·
May 06

Altimmune to Report First Quarter 2026 Financial Results and Provide Business Update on May 13, 2026

THOMSON REUTERS
·
May 06

Immunocore reports first quarter financial results and provides a business update

GlobeNewswire
·
May 06

ALT Resources Sets Date and Venue for 2026 Annual General Meeting

TIPRANKS
·
May 06

CCL Industries closes ALT Technologies acquisition

TIPRANKS
·
May 01

Altimmune closes USD 225 million follow-on stock offering with warrants

Reuters
·
Apr 27

Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities

THOMSON REUTERS
·
Apr 27

Altimmune Inc: Financing Funds Operations Through Anticipated Phase 3 Mash 52-Week Data Readout

THOMSON REUTERS
·
Apr 27

Altimmune Inc: Intends to Use Net Proceeds to Fund Its Upcoming Phase 3 Trial in Mash, Expects to Initiate Its Phase 3 Trial in Mash in H2

THOMSON REUTERS
·
Apr 27

Brii Bio Presents Cross-Study Analysis of Post-Treatment HBsAg Rebound at APASL 2026

prnewswire
·
Apr 26

Altimmune upgraded to Neutral from Sell at Goldman Sachs

TIPRANKS
·
Apr 24

BUZZ-U.S. STOCKS ON THE MOVE- Lululemon, United Rentals, cannabis stocks

Reuters
·
Apr 24

Altimmune Shares Drop After $225 Million Offering Prices

Dow Jones
·
Apr 23

ALT Resources Advances Tartana Reverse Takeover and Secures £208,750 Funding

TIPRANKS
·
Apr 23

Altimmune prices oversubscribed USD 225 million public offering with warrants

Reuters
·
Apr 23

Altimmune Announces Pricing of $225 Million Oversubscribed Public Offering of Securities

THOMSON REUTERS
·
Apr 23

BRIEF-Altimmune Announces Proposed Underwritten Public Offering Of Securities

Reuters
·
Apr 23

Altimmune launches underwritten public offering with common stock, warrants

Reuters
·
Apr 23

Altimmune Announces Proposed Underwritten Public Offering of Securities

THOMSON REUTERS
·
Apr 23

Altimmune Inc - Net Proceeds to Fund Phase 3 Mash Trial and General Purposes

THOMSON REUTERS
·
Apr 23